Hepatocellular carcinoma in survivors after Fontan operation: a case-control study

By sjmartinez • December 13, 2023

Kim YY, Lluri G, Haeffele C, Daugherty T, Krasuski RA, Serfas JD, de Freitas RA, Porlier A, Lubert AM, Wu FM, Valente AM, Krieger EV, Buber J, Rodriguez FH 3rd, Gaignard S, Saraf A, Hindes M, Earing MG, Lewis MJ, Rosenbaum MS, Zaidi AN, Hopkins K, Bradley EA, Cedars AM, Ko JL, Franklin WJ, Frederickson A, Ginde S, Grewal J, Nyman A, Min J, Schluger C, Rand E, Rosenthal BE, Hilscher M, Rychik J, Hoteit MA. Hepatocellular carcinoma in survivors after Fontan operation: a case-control study. Eur Heart J. 2023 Dec 12:ehad788. doi: 10.1093/eurheartj/ehad788. Epub ahead of print. PMID: 38085593.

Tags: Cardiology/Epi, congenital heart disease, Fontan operation, Fontan-associated liver disease, Hepatocellular carcinoma, Publications

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. Heart Rhythm. 2024 May;21(5):710-711. doi: 10.1016/j.hrthm.2024.03.016. PMID: 38692819.

Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice

Kalanski S, Pradhan S, Hon A, Xia Y, Safvati N, Rivera JC, Lu M, Demer LL, Tintut Y. Effects of Empagliflozin on vascular and skeletal[...]

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. JACC Clin Electrophysiol. 2024 Apr 19:S2405-500X(24)00185-3. doi: 10.1016/j.jacep.2024.03.004.[...]